Vaccine used in Azerbaijan is effective against British strain - OFFICIAL
Health
- 18 March, 2021
- 09:02
The CoronoVAC vaccine produced by the Chinese company SinoVac, which is used against coronavirus infection in Azerbaijan, is also effective against new strains, the National Center for Hematology and Transfusion told Report.
501Y.V1 and B.1.1.7 (British version) were found in three samples analyzed by the Sars Cov-2 genome at the Center's Genetic Diagnostic Center.
Azerbaijan started the vaccination process on January 18. Vaccination is performed voluntarily and at state expense. To date, 468,826 people in the country have been vaccinated.
Latest News
13:25
Ukrainian ambassador thanks Azerbaijan for its support, supply of generators
Foreign policy13:23
EU plans Energy Days in Azerbaijan under Covenant of Mayors initiative
Energy13:12
Ritter: No discussions on extending EU mission's mandate in Armenia
Region13:06
Police in France detain 9 people in suspected massive Louvre ticket fraud scheme
Other countries13:04
Azerbaijani parliament adopts new rules for tax registration of non-residents in e-commerce
Finance12:56
Energy efficiency key to Azerbaijan's sustainable dev't agenda
Energy12:50
Azerbaijan, UN mull co-op in intercultural dialogue
Cultural policy12:42
Earthquake of magnitude 5.5 strikes Pakistan's Balochistan region
Other countries12:42